T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.

There is growing evidence that CD8+ cytotoxic T lymphocyte (CTL) responses can contribute to long-term remission of many malignancies. The etiological agent of adult T-cell leukemia/lymphoma (ATL), human T lymphotropic virus type-1 (HTLV-1), contains highly immunogenic CTL epitopes, but ATL patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Aileen G Rowan, Aviva Witkover, Anat Melamed, Yuetsu Tanaka, Lucy B M Cook, Paul Fields, Graham P Taylor, Charles R M Bangham
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-11-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006030&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726657637646336
author Aileen G Rowan
Aviva Witkover
Anat Melamed
Yuetsu Tanaka
Lucy B M Cook
Lucy B M Cook
Paul Fields
Graham P Taylor
Charles R M Bangham
author_facet Aileen G Rowan
Aviva Witkover
Anat Melamed
Yuetsu Tanaka
Lucy B M Cook
Lucy B M Cook
Paul Fields
Graham P Taylor
Charles R M Bangham
author_sort Aileen G Rowan
collection DOAJ
description There is growing evidence that CD8+ cytotoxic T lymphocyte (CTL) responses can contribute to long-term remission of many malignancies. The etiological agent of adult T-cell leukemia/lymphoma (ATL), human T lymphotropic virus type-1 (HTLV-1), contains highly immunogenic CTL epitopes, but ATL patients typically have low frequencies of cytokine-producing HTLV-1-specific CD8+ cells in the circulation. It remains unclear whether patients with ATL possess CTLs that can kill the malignant HTLV-1 infected clone. Here we used flow cytometric staining of TCRVβ and cell adhesion molecule-1 (CADM1) to identify monoclonal populations of HTLV-1-infected T cells in the peripheral blood of patients with ATL. Thus, we quantified the rate of CD8+-mediated killing of the putative malignant clone in ex vivo blood samples. We observed that CD8+ cells from ATL patients were unable to lyse autologous ATL clones when tested directly ex vivo. However, short in vitro culture restored the ability of CD8+ cells to kill ex vivo ATL clones in some donors. The capacity of CD8+ cells to lyse HTLV-1 infected cells which expressed the viral sense strand gene products was significantly enhanced after in vitro culture, and donors with an ATL clone that expressed the HTLV-1 Tax gene were most likely to make a detectable lytic CD8+ response to the ATL cells. We conclude that some patients with ATL possess functional tumour-specific CTLs which could be exploited to contribute to control of the disease.
format Article
id doaj-art-07d94a3d9efc4eee96bb2ade02861375
institution DOAJ
issn 1553-7366
1553-7374
language English
publishDate 2016-11-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-07d94a3d9efc4eee96bb2ade028613752025-08-20T03:10:07ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742016-11-011211e100603010.1371/journal.ppat.1006030T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.Aileen G RowanAviva WitkoverAnat MelamedYuetsu TanakaLucy B M CookLucy B M CookPaul FieldsGraham P TaylorCharles R M BanghamThere is growing evidence that CD8+ cytotoxic T lymphocyte (CTL) responses can contribute to long-term remission of many malignancies. The etiological agent of adult T-cell leukemia/lymphoma (ATL), human T lymphotropic virus type-1 (HTLV-1), contains highly immunogenic CTL epitopes, but ATL patients typically have low frequencies of cytokine-producing HTLV-1-specific CD8+ cells in the circulation. It remains unclear whether patients with ATL possess CTLs that can kill the malignant HTLV-1 infected clone. Here we used flow cytometric staining of TCRVβ and cell adhesion molecule-1 (CADM1) to identify monoclonal populations of HTLV-1-infected T cells in the peripheral blood of patients with ATL. Thus, we quantified the rate of CD8+-mediated killing of the putative malignant clone in ex vivo blood samples. We observed that CD8+ cells from ATL patients were unable to lyse autologous ATL clones when tested directly ex vivo. However, short in vitro culture restored the ability of CD8+ cells to kill ex vivo ATL clones in some donors. The capacity of CD8+ cells to lyse HTLV-1 infected cells which expressed the viral sense strand gene products was significantly enhanced after in vitro culture, and donors with an ATL clone that expressed the HTLV-1 Tax gene were most likely to make a detectable lytic CD8+ response to the ATL cells. We conclude that some patients with ATL possess functional tumour-specific CTLs which could be exploited to contribute to control of the disease.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006030&type=printable
spellingShingle Aileen G Rowan
Aviva Witkover
Anat Melamed
Yuetsu Tanaka
Lucy B M Cook
Lucy B M Cook
Paul Fields
Graham P Taylor
Charles R M Bangham
T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.
PLoS Pathogens
title T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.
title_full T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.
title_fullStr T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.
title_full_unstemmed T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.
title_short T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.
title_sort t cell receptor vβ staining identifies the malignant clone in adult t cell leukemia and reveals killing of leukemia cells by autologous cd8 t cells
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006030&type=printable
work_keys_str_mv AT aileengrowan tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT avivawitkover tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT anatmelamed tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT yuetsutanaka tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT lucybmcook tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT lucybmcook tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT paulfields tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT grahamptaylor tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells
AT charlesrmbangham tcellreceptorvbstainingidentifiesthemalignantcloneinadulttcellleukemiaandrevealskillingofleukemiacellsbyautologouscd8tcells